Insufficient scRNA-seq data for expression of CRYBB3 at single-cell level.
Insufficient scRNA-seq data for expression of CRYBB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 58.31 | 650 / 653 | 70% | 2.11 | 425 / 605 |
kidney | 100% | 61.79 | 89 / 89 | 62% | 3.71 | 563 / 901 |
esophagus | 81% | 15.92 | 1172 / 1445 | 77% | 2.11 | 140 / 183 |
liver | 100% | 47.60 | 225 / 226 | 42% | 0.94 | 169 / 406 |
lung | 84% | 13.24 | 485 / 578 | 53% | 1.82 | 609 / 1155 |
pancreas | 76% | 8.90 | 249 / 328 | 57% | 1.31 | 102 / 178 |
uterus | 74% | 9.83 | 126 / 170 | 58% | 1.54 | 265 / 459 |
ovary | 71% | 6.51 | 128 / 180 | 60% | 1.76 | 259 / 430 |
intestine | 77% | 17.18 | 742 / 966 | 54% | 1.15 | 285 / 527 |
prostate | 94% | 45.11 | 230 / 245 | 36% | 0.72 | 180 / 502 |
stomach | 73% | 7.94 | 262 / 359 | 52% | 1.10 | 149 / 286 |
breast | 78% | 14.47 | 356 / 459 | 34% | 0.64 | 377 / 1118 |
bladder | 67% | 8.71 | 14 / 21 | 44% | 1.26 | 224 / 504 |
adrenal gland | 93% | 19.49 | 240 / 258 | 9% | 0.17 | 20 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.53 | 1 / 1 |
blood vessel | 90% | 19.69 | 1204 / 1335 | 0% | 0 | 0 / 0 |
skin | 64% | 11.45 | 1163 / 1809 | 2% | 0.02 | 8 / 472 |
spleen | 66% | 6.17 | 159 / 241 | 0% | 0 | 0 / 0 |
heart | 63% | 6.70 | 546 / 861 | 0% | 0 | 0 / 0 |
adipose | 58% | 5.82 | 700 / 1204 | 0% | 0 | 0 / 0 |
brain | 54% | 4.53 | 1422 / 2642 | 4% | 0.06 | 25 / 705 |
tonsil | 0% | 0 | 0 / 0 | 56% | 1.15 | 25 / 45 |
muscle | 51% | 4.69 | 413 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 9% | 0.60 | 88 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.09 | 4 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002088 | Biological process | lens development in camera-type eye |
GO_0007601 | Biological process | visual perception |
GO_0005212 | Molecular function | structural constituent of eye lens |
GO_0005515 | Molecular function | protein binding |
Gene name | CRYBB3 |
Protein name | Beta-crystallin B3 (Beta-B3 crystallin) Beta-crystallin B3 (Beta-B3 crystallin) [Cleaved into: Beta-crystallin B3, N-terminally processed] |
Synonyms | CRYB3 |
Description | FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. . |
Accessions | ENST00000215855.7 B1AHR5 P26998 ENST00000404334.1 |